Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
co decrease » _ decrease (Expand Search), nn decrease (Expand Search), c decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
co decrease » _ decrease (Expand Search), nn decrease (Expand Search), c decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
981
Image 3_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.tif
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
982
Table 7_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.xls
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
983
Image 2_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.tif
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
984
Image 1_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.tif
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
985
Table 8_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.xls
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
986
Table 9_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.xls
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
987
Image 7_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.tif
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
988
Table 5_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.xlsx
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
989
Image 4_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.tif
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
990
Image 5_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.tif
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
991
Table 1_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.xls
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
992
Table 6_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.xls
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
993
Table 2_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.docx
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
994
Table 4_Integrative RNA-seq and CLIP-seq analysis reveals hnRNP-F regulation of TNFα/NFκB signaling in high-glucose conditions.xlsx
Published 2025“…Meanwhile, hnRNP-F may function in the co-regulation of alternative splicing events in cells by interacting with ZFP36 to form a complex.…”
-
995
Antibodies used for flow cytometry.
Published 2025“…In AN-LSCs, 75 µM CoCl₂ treatment resulted in a decrease in <i>CASP3</i> (p = 0.049), <i>CASP7</i> (p = 0.041) and <i>BCL2</i> (p = 0.0218) mRNA and Bcl-2 protein levels (p = 0.0405) and an increase of TNF-α protein levels in the cell culture supernatant (p = 0.0251).…”
-
996
Primer pairs used for qPCR.
Published 2025“…In AN-LSCs, 75 µM CoCl₂ treatment resulted in a decrease in <i>CASP3</i> (p = 0.049), <i>CASP7</i> (p = 0.041) and <i>BCL2</i> (p = 0.0218) mRNA and Bcl-2 protein levels (p = 0.0405) and an increase of TNF-α protein levels in the cell culture supernatant (p = 0.0251).…”
-
997
Ama controls the pool of myoblast number independently of Nrt.
Published 2024“…Co-expressing UAS-Ama with UAS-HtlDN (FGFR DN; Ama OE) partially rescues the decrease of myoblast number of <i>UAS-HtlDN;</i> UAS-mCherryRNAi (FGFR DN) expression. …”
-
998
Included studies basic characteristics.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
999
Forest plot for FVC.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”
-
1000
All data extracted.
Published 2025“…Compared to standard treatment, QJHTD significantly improved pulmonary function, with increases in FEV1 (MD = 0.32, 95% CI [0.25, 0.38], <i>p </i>= 0.000), FVC (MD = 0.30, 95% CI [0.22, 0.37], <i>p </i>= 0.000), FEV1/FVC (MD = 5.58, 95% CI [4.81, 6.34], <i>p </i>= 0.000), and PaO<sub>2</sub> (MD = 9.62, 95% CI [6.17, 13.08], <i>p </i>= 0.000), and a decrease in PaCO<sub>2</sub> (MD = -9.12, 95% CI [–11.96, –6.28], <i>p </i>= 0.000). …”